• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强女性健康:HPV疫苗接种与浸润性宫颈癌预防的见解

Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer.

作者信息

Rathod Sachin, Potdar Jyotsna, Gupta Aishwarya, Sethi Neha, Dande Anubha

机构信息

Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

出版信息

Cureus. 2023 Nov 27;15(11):e49523. doi: 10.7759/cureus.49523. eCollection 2023 Nov.

DOI:10.7759/cureus.49523
PMID:38156129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10752828/
Abstract

This review article provides a comprehensive analysis of the role of human papillomavirus (HPV) vaccination in empowering women's health by preventing invasive cervical cancer. Cervical cancer remains a significant global health concern, with HPV infection identified as a primary causative factor. The review synthesizes current research findings, epidemiological data, and clinical outcomes to offer a nuanced understanding of the impact of HPV vaccination on cervical cancer prevention. The article explores the biology of HPV, emphasizing its association with cervical carcinogenesis and the development of precancerous lesions. It delves into the epidemiology of HPV infection, highlighting the global prevalence and the burden of cervical cancer, particularly in low-resource settings. The socio-economic factors influencing HPV transmission and cervical cancer incidence are also discussed. The focus of the review is on the efficacy and safety of HPV vaccines, including an examination of vaccine types, dosages, and long-term effectiveness. Insights into the immunological responses triggered by vaccination, as well as the duration of protection against HPV infection and associated cancers, are presented. Special attention is given to addressing myths and misconceptions surrounding HPV vaccination, aiming to enhance public awareness and acceptance. Additionally, the review discusses the impact of vaccination programs on population-wide HPV prevalence and the subsequent reduction in cervical cancer rates. It explores challenges related to vaccine accessibility, affordability, and coverage, especially in underserved populations. Strategies for improving vaccine uptake and ensuring equitable distribution are considered, with a focus on empowering women through education and healthcare access. Furthermore, the article touches upon emerging trends in HPV research, such as the development of next-generation vaccines, therapeutic interventions for existing infections, and the potential for global HPV elimination. The integration of HPV vaccination into comprehensive women's health programs is advocated, emphasizing the importance of a holistic approach to cervical cancer prevention. In conclusion, this review provides a multifaceted exploration of HPV vaccination as a pivotal tool in empowering women's health by preventing invasive cervical cancer. The synthesis of current knowledge underscores the need for continued research, education, and global collaboration to ensure the widespread success of HPV vaccination initiatives, ultimately contributing to the advancement of women's health worldwide.

摘要

这篇综述文章全面分析了人乳头瘤病毒(HPV)疫苗接种在通过预防浸润性宫颈癌增强女性健康方面的作用。宫颈癌仍然是一个重大的全球健康问题,HPV感染被确定为主要致病因素。该综述综合了当前的研究结果、流行病学数据和临床结果,以细致入微地理解HPV疫苗接种对宫颈癌预防的影响。文章探讨了HPV的生物学特性,强调其与宫颈癌发生及癌前病变发展的关联。它深入研究了HPV感染的流行病学,突出了全球流行情况以及宫颈癌的负担,特别是在资源匮乏地区。还讨论了影响HPV传播和宫颈癌发病率的社会经济因素。综述的重点是HPV疫苗的有效性和安全性,包括对疫苗类型、剂量和长期有效性的研究。介绍了对疫苗接种引发的免疫反应的见解,以及针对HPV感染和相关癌症的保护持续时间。特别关注消除围绕HPV疫苗接种的误解和错误观念,旨在提高公众意识和接受度。此外,综述讨论了疫苗接种计划对全人群HPV流行率的影响以及随后宫颈癌发病率的降低。它探讨了与疫苗可及性、可负担性和覆盖率相关的挑战,尤其是在服务不足的人群中。考虑了提高疫苗接种率和确保公平分配的策略,重点是通过教育和医疗服务赋予女性权力。此外,文章还涉及HPV研究的新趋势,如下一代疫苗的开发、现有感染的治疗干预措施以及全球消除HPV的潜力。提倡将HPV疫苗接种纳入全面的女性健康计划,强调采取整体方法预防宫颈癌的重要性。总之,本综述对HPV疫苗接种进行了多方面的探讨,认为它是通过预防浸润性宫颈癌增强女性健康的关键工具。当前知识的综合强调了持续研究、教育和全球合作的必要性,以确保HPV疫苗接种计划的广泛成功,最终促进全球女性健康的进步。

相似文献

1
Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer.增强女性健康:HPV疫苗接种与浸润性宫颈癌预防的见解
Cureus. 2023 Nov 27;15(11):e49523. doi: 10.7759/cureus.49523. eCollection 2023 Nov.
2
Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.海地移民女性对人乳头瘤病毒和宫颈癌的认知:对疫苗可接受性的影响
Educ Health (Abingdon). 2011 Dec;24(3):479. Epub 2011 Dec 7.
3
Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study.高危型人乳头瘤病毒(HPV)亚型的流行情况及HPV疫苗预防宫颈上皮病变的效果:一项德国研究的调查与见解
Life (Basel). 2023 Jul 27;13(8):1637. doi: 10.3390/life13081637.
4
Empowering Women's Health: Examining the Impact of Human Papillomavirus (HPV) Vaccination on Cervical Cancer Treatment and Beyond.增强女性健康:审视人乳头瘤病毒(HPV)疫苗接种对宫颈癌治疗及其他方面的影响。
Cureus. 2024 Aug 20;16(8):e67287. doi: 10.7759/cureus.67287. eCollection 2024 Aug.
5
Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.人乳头瘤病毒(HPV)疫苗用于预防HPV 16/18引起的宫颈癌及其癌前病变。
GMS Health Technol Assess. 2009 Mar 11;5:Doc04. doi: 10.3205/hta000066.
6
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.宫颈癌及相关宫颈疾病的预防:致癌性人乳头瘤病毒(HPV)疫苗接种的成本效益综述
J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217.
7
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
8
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.实现世界卫生组织宫颈癌消除目标的死亡率影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):591-603. doi: 10.1016/S0140-6736(20)30157-4. Epub 2020 Jan 30.
9
"If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study.“如果无法治疗 HPV,那为何要进行检测?”——女性对宫颈癌预防方法不断变化的态度:一项焦点小组研究。
BMC Womens Health. 2014 May 6;14:64. doi: 10.1186/1472-6874-14-64.
10
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.评估在瑞士开展中性性别 HPV 疫苗接种项目中,将 4 价 HPV 疫苗转换为 9 价 HPV 疫苗对宫颈癌的流行病学影响。
BMC Public Health. 2020 May 12;20(1):671. doi: 10.1186/s12889-020-08840-0.

引用本文的文献

1
Regional Disparities in HPV Vaccination Coverage Among Girls Aged 9 to 14 Years in Togo: Lessons Learned from the Recent Supplementary Immunization Activities.多哥9至14岁女孩人乳头瘤病毒疫苗接种覆盖率的地区差异:从近期补充免疫活动中吸取的经验教训
Vaccines (Basel). 2025 Mar 31;13(4):373. doi: 10.3390/vaccines13040373.
2
Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology.解析肿瘤学中免疫疗法、肿瘤微环境和骨骼肌生物力学之间的关系。
Front Immunol. 2025 Apr 2;16:1572821. doi: 10.3389/fimmu.2025.1572821. eCollection 2025.
3
Immunotherapeutic effects of TCL-E5 and TCL-E5-pulsed DCs: two novel HPV therapeutic vaccine candidates.TCL-E5和TCL-E5脉冲树突状细胞的免疫治疗效果:两种新型人乳头瘤病毒治疗性疫苗候选物。
Immunotherapy. 2025 Feb;17(3):191-199. doi: 10.1080/1750743X.2025.2478814. Epub 2025 Mar 18.
4
Regulation of Granzymes A and B by High-Risk HPV: Impact on Immune Evasion and Carcinogenesis.高危型人乳头瘤病毒对颗粒酶A和颗粒酶B的调控:对免疫逃逸和致癌作用的影响
Viruses. 2025 Feb 3;17(2):221. doi: 10.3390/v17020221.
5
Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of disease study 2021.1990年至2021年不同年龄和地区的宫颈癌负担及归因风险因素,以及未来负担预测:2021年全球疾病负担研究结果
Front Oncol. 2025 Feb 7;15:1541452. doi: 10.3389/fonc.2025.1541452. eCollection 2025.
6
Empowering India's fight against cervical cancer: Harnessing routine HPV immunisation.助力印度抗击宫颈癌:利用常规人乳头瘤病毒免疫接种
J Family Med Prim Care. 2025 Jan;14(1):22-28. doi: 10.4103/jfmpc.jfmpc_678_24. Epub 2025 Jan 13.
7
Knowledge, attitude, and reasons for non-uptake of human papilloma virus vaccination among nursing students.护理专业学生对人乳头瘤病毒疫苗接种的认知、态度及未接种原因
BMC Med. 2025 Jan 21;23(1):35. doi: 10.1186/s12916-025-03874-w.
8
A critical evaluation of the status of HPV vaccination in São Paulo State, Brazil.巴西圣保罗州 HPV 疫苗接种状况的批判性评估。
Clinics (Sao Paulo). 2024 Nov 6;79:100526. doi: 10.1016/j.clinsp.2024.100526. eCollection 2024.
9
Factors influencing human papillomavirus vaccine uptake among parents and teachers of schoolgirls in Saudi Arabia: a cross-sectional study.影响沙特阿拉伯女校学生家长和教师接种人乳头瘤病毒疫苗的因素:一项横断面研究。
Front Public Health. 2024 Oct 16;12:1403634. doi: 10.3389/fpubh.2024.1403634. eCollection 2024.
10
Optimizing Human Papillomavirus (HPV) Screening: Urine Sample Analysis and Associated Factors in Uzbekistan.优化人乳头瘤病毒(HPV)筛查:乌兹别克斯坦的尿液样本分析及相关因素
Cureus. 2024 Sep 20;16(9):e69816. doi: 10.7759/cureus.69816. eCollection 2024 Sep.

本文引用的文献

1
Shaping global vaccine acceptance with localized knowledge: a report from the inaugural VARN2022 conference.用本地化知识塑造全球疫苗接受度:首届VARN2022会议报告
BMC Proc. 2023 Oct 5;17(Suppl 7):26. doi: 10.1186/s12919-023-00280-z.
2
Public Health Approach in the Elimination and Control of Cervical Cancer: A Review.消除和控制宫颈癌的公共卫生方法:综述
Cureus. 2023 Sep 1;15(9):e44543. doi: 10.7759/cureus.44543. eCollection 2023 Sep.
3
Addressing Cancer Disparities Through Community Engagement: Lessons and Best Practices.通过社区参与解决癌症差异:经验教训与最佳实践
Cureus. 2023 Aug 14;15(8):e43445. doi: 10.7759/cureus.43445. eCollection 2023 Aug.
4
Scaling and sustaining COVID-19 vaccination through meaningful community engagement and care coordination for underserved communities: hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial.通过有意义的社区参与和为服务不足社区提供的护理协调来扩大和维持 COVID-19 疫苗接种:混合 3 型有效性-实施序贯多项分配随机试验。
Implement Sci. 2023 Jul 14;18(1):28. doi: 10.1186/s13012-023-01283-2.
5
Innovations in healthcare delivery: Human papilloma virus self sampling diagnostics and participatory innovations for CCS.医疗保健服务创新:人乳头瘤病毒自我采样诊断和 CCS 的参与式创新。
Cancer Med. 2023 Jul;12(14):15544-15551. doi: 10.1002/cam4.6201. Epub 2023 Jun 16.
6
Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.人乳头瘤病毒疫苗在中低收入国家的接种:进展、障碍和未来展望。
Front Immunol. 2023 May 12;14:1150238. doi: 10.3389/fimmu.2023.1150238. eCollection 2023.
7
Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings.美国三个医疗保健环境中的宫颈癌筛查中的种族和民族差异。
Am J Prev Med. 2023 Oct;65(4):667-677. doi: 10.1016/j.amepre.2023.04.016. Epub 2023 May 3.
8
Barriers and supports for uptake of human papillomavirus vaccination in Indigenous people globally: A systematic review.全球原住民接种人乳头瘤病毒疫苗的障碍与支持因素:一项系统综述
PLOS Glob Public Health. 2023 Jan 6;3(1):e0001406. doi: 10.1371/journal.pgph.0001406. eCollection 2023.
9
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
10
Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives.人乳头瘤病毒(HPV)疫苗接种计划在中低收入国家推出的关键决策因素:全球和国家利益相关者的观点。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2150454. doi: 10.1080/21645515.2022.2150454. Epub 2022 Dec 9.